April 15th, 2017
•Here, we show the generation of human engineered heart tissue from induced pluripotent stem cells (hiPSC)-derived cardiomyocytes. We present a method to analyze contraction force and exemplary alteration of contraction pattern by the hERG channel inhibitor E-4031. This method shows high level of robustness and suitability for cardiac drug screening.
Tags
Related Videos
Bioluminescence Imaging for Assessment of Immune Responses Following Implantation of Engineered Heart Tissue (EHT)
Self-reporting Scaffolds for 3-Dimensional Cell Culture
Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
Hollow Fiber Bioreactors for In Vivo-like Mammalian Tissue Culture
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
Copyright © 2024 MyJoVE Corporation. 판권 소유